1,498
Views
3
CrossRef citations to date
0
Altmetric
Articles

Prokinetic effects of diatrizoate meglumine (Gastrografin®) in a zebrafish for opioid-induced constipation model

, , ORCID Icon, , , , , , , & show all
Pages 264-271 | Received 31 Jan 2021, Accepted 27 Sep 2021, Published online: 25 Oct 2021

References

  • Al-Saffar A, Takemi S, Saaed HK, Sakata I, Sakai T. 2019. Utility of animal gastrointestinal motility and transit models in functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol. 40–41:101633. eng.
  • Branco BC, Barmparas G, Schnuriger B, Inaba K, Chan LS, Demetriades D. 2010. Systematic review and meta-analysis of the diagnostic and therapeutic role of water-soluble contrast agent in adhesive small bowel obstruction. British J Surg. 97(4):470–478. eng.
  • De Giorgio R, Ruggeri E, Stanghellini V, Eusebi LH, Bazzoli F, Chiarioni G. 2015. Chronic constipation in the elderly: a primer for the gastroenterologist. BMC Gastroenterol. 15:130. eng.
  • Di Saverio S, Coccolini F, Galati M, Smerieri N, Biffl WL, Ansaloni L, Tugnoli G, Velmahos GC, Sartelli M, Bendinelli C, et al. 2013. Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2013 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group. World J Emerg Surg. 8(1):42. eng.
  • Everhart JE, Ruhl CE. 2009. Burden of digestive diseases in the United States part II: lower gastrointestinal diseases. Gastroenterology. 136(3):741–754. eng.
  • Farmer AD, Holt CB, Downes TJ, Ruggeri E, Del Vecchio S, De Giorgio R. 2018. Pathophysiology, diagnosis, and management of opioid-induced constipation. Lancet Gastroenterol Hepatol. 3(3):203–212. eng.
  • Field HA, Kelley KA, Martell L, Goldstein AM, Serluca FC. 2009. Analysis of gastrointestinal physiology using a novel intestinal transit assay in zebrafish. Neurogastroenterol Motil. 21(3):304–312.
  • Forootan M, Bagheri N, Darvishi M. 2018. Chronic constipation: A review of literature. Medicine (Baltimore). 97(20):e10631. eng.
  • Glia A, Lindberg G. 1997. Quality of life in patients with different types of functional constipation. Scand J Gastroenterol. 32(11):1083–1089. eng.
  • Harrison AP, Erlwanger KH, Elbrond VS, Andersen NK, Unmack MA. 2004. Gastrointestinal-tract models and techniques for use in safety pharmacology. J Pharmacol Toxicol Methods. 49(3):187–199. eng.
  • Ho DH, Lee H, Son I, Seol W. 2019. G2019s LRRK2 promotes mitochondrial fission and increases TNFα-mediated neuroinflammation responses. Anim Cells Syst. 23(2):106–111.
  • Holmberg A, Olsson C, Holmgren S. 2006. The effects of endogenous and exogenous nitric oxide on gut motility in zebrafish Danio rerio embryos and larvae. J Exp Biol. 209(Pt 13):2472–2479. eng.
  • Holzer P. 2009. Opioid receptors in the gastrointestinal tract. Regul Pept. 155(1–3):11–17. eng.
  • Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M, Collins JE, Humphray S, McLaren K, Matthews L, et al. 2013. The zebrafish reference genome sequence and its relationship to the human genome. Nature. 496(7446):498–503. eng.
  • Kalso E, Edwards JE, Moore RA, McQuay HJ. 2004. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 112(3):372–380. eng.
  • Kanungo J, Cuevas E, Ali SF, Paule MG. 2014. Zebrafish model in drug safety assessment. Curr Pharm Des. 20(34):5416–5429. eng.
  • Klaschik E, Nauck F, Ostgathe C. 2003. Constipation–modern laxative therapy. Support Care Cancer. 11(11):679–685.
  • Marks L, Beard E, Cobey D, Moore N, Motyer V, Valentin JP, Ewart L. 2013. An evaluation of the non-invasive faecal pellet assessment method as an early drug discovery screen for gastrointestinal liability. J Pharmacol Toxicol Methods. 68(1):123–136. eng.
  • McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli-Goudas M, Chew PW, Lau J, Carr D. 2003. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain. 4(5):231–256. eng.
  • Rao SS, Seaton K, Miller MJ, Schulze K, Brown CK, Paulson J, Zimmerman B. 2007. Psychological profiles and quality of life differ between patients with dyssynergia and those with slow transit constipation. J Psychosom Res. 63(4):441–449. eng.
  • Rich A, Gordon S, Brown C, Gibbons SJ, Schaefer K, Hennig G, Farrugia G. 2013. Kit signaling is required for development of coordinated motility patterns in zebrafish gastrointestinal tract. Zebrafish. 10(2):154–160.
  • Sanchez MI, Bercik P. 2011. Epidemiology and burden of chronic constipation. Can. J Gastroenterol. 25(Suppl B):11b–15b. eng.
  • Shi Y, Zhang Y, Zhao F, Ruan H, Huang H, Luo L, Li L. 2014. Acetylcholine serves as a derepressor in loperamide-induced opioid-induced bowel dysfunction (OIBD) in zebrafish. Sci Rep. 4:5602.
  • Shin MK, Yang SM, Han IS. 2020. Capsaicin suppresses liver fat accumulation in high-fat diet-induced NAFLD mice. Anim Cells Syst. 24(4):214–219.
  • Tong WD, Liu BH, Zhang LY, Xiong RP, Liu P, Zhang SB. 2005. Expression of c-kit messenger ribonucleic acid and c-kit protein in sigmoid colon of patients with slow transit constipation. Int J Colorectal Dis. 20(4):363–367.
  • Wintola OA, Sunmonu TO, Afolayan AJ. 2010. The effect of aloe ferox mill in the treatment of loperamide-induced constipation in wistar rats. BMC Gastroenterol. 10:95. eng.